RadNet, Inc. (RDNT) earnings
RDNT earnings moved a median of +1.10% by the close. Quarterly and annual RDNT reports and results, each read against the price at its own news timestamp. Back to the RDNT overview →
28 measured RDNT earnings events.
Where these RDNT earnings landedvs 27 measured RDNT earnings reactions
| Middle 50% of RDNT earnings reactions | -0.66% to +3.77% |
|---|---|
| Median reaction (to close) | +1.10% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 RDNT earnings events with a measured close landed between -0.66% and +3.77%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call | Press release | +0.69% | -3.35% | |
| Form 10-Q RadNet, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.93% | +2.75% | |
| RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call | Press release | +0.78% | +0.07% | |
| Form 10-K RadNet, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.07% | -0.53% | |
| RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA?¹? and Releases 2026 Financial Guidance | Press release | +1.73% | +5.93% | |
| RadNet, Inc. Announces Date of its Fourth Quarter 2025 Financial Results Conference Call | Press release | +0.53% | +1.86% | |
| Form 10-Q RadNet, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.55% | -2.25% | |
| RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Results Conference Call | Press release | -1.41% | -0.04% | |
| Form 10-Q RadNet, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.28% | — | |
| RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call | Press release | -0.22% | +1.81% | |
| Form 10-Q RadNet, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.54% | +4.80% | |
| Form 10-K/A RadNet, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.21% | +0.63% | |
| RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call | Press release | -0.69% | +1.86% | |
| Form 10-K RadNet, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.69% | +4.88% | |
| RadNet Reports Fourth Quarter 2024 Results, Including Record Revenue and Adjusted EBITDA(1) and Releases 2025 Financial Guidance | Press release | +0.10% | +10.94% | |
| RadNet, Inc. Announces Date of its Fourth Quarter 2024 Financial Results Conference Call | Press release | -0.24% | -2.36% | |
| Form 10-Q RadNet, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.85% | |
| RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call | Press release | +0.34% | -0.45% | |
| Form 10-Q RadNet, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.84% | -1.78% | |
| RadNet, Inc. Announces Date of its Second Quarter 2024 Financial Results Conference Call | Press release | +1.20% | +2.73% | |
| Form 10-Q RadNet, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.27% | +0.81% | |
| RadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA(1) and Adjusted Earnings(3) and Revises Upwards 2024 Financial Guidance Ranges | Press release | +0.18% | +4.94% | |
| RadNet, Inc. Announces Date of its First Quarter 2024 Financial Results Conference Call | Press release | -0.20% | +1.10% | |
| Form 10-K RadNet, Inc. For: Dec 31 | SEC filing · Form 10-K | +7.40% | +10.88% | |
| RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA(1), Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment | Press release | +7.40% | +10.88% | |
| RadNet, Inc. Announces Date of its Fourth Quarter 2023 Financial Results Conference Call | Press release | +0.37% | -1.40% | |
| Form 10-Q RadNet, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.53% | -0.78% | |
| RadNet, Inc. Announces Date of its Third Quarter 2023 Financial Results Conference Call | Press release | -0.07% | +2.61% |
Keep exploring
More RDNT: analyst actions → · SEC filings → · RDNT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EISAI CO S/ADR (ESALY) | 365 | 0.00% | 33% |
| Fennec Pharmaceuticals Inc. (FENC) | 364 | +0.09% | 51% |
| Aerpio Pharmaceuticals, Inc (ARPO) | 363 | 0.00% | 32% |
| Bio-Techne Corp (TECH) | 363 | -0.06% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.